First-in-human pharmacokinetic, pharmacodynamics, and safety profile of a FAS associated factor 1 inhibitor (KM-819) in healthy volunteers

Authors
Category Primary study
ConferenceClinical Pharmacology and Therapeutics
Year 2018
This article has no abstract
Epistemonikos ID: becb603c9d363c8457283ea89a30ed361a926e0c
First added on: Apr 29, 2026